Improving the framework titanium (Ti) of titanium silicalite-1 (TS-1) zeolites and creating inter-crystalline mesoporosity are two ways to enhance the catalytic properties of TS-1 for hydroxylation of phenol. Most researches only used one of the ways. In this study, we successfully synthesized of hierarchical Titanium-Rich (Ti-rich) TS-1. Ti-rich TS-1 was synthesized in the presence of ammonium carbonate ((NH 4 ) 2 CO 3 ). The framework Ti content of TS-1 zeolites synthesized by different content of (NH 4 ) 2 CO 3 was studied by X-ray fluorescence (XRF), Fourier transform infrared spectra (FTIR) and ultraviolet visible spectra, the framework Ti content was significantly increased by using (NH 4 ) 2 CO 3 as crystallization-mediating agent. The synthesized samples were evaluated in hydroxylation of phenol. When the molar ratio of ammonium carbonate and tetraethyl orthosilicate in the synthesis gel was 0.2, the molar ratio of Si/Ti reached 34.43 and the Ti-rich TS-1 shows the optimum catalytic activity in hydroxylation of phenol. The post-modification with aqueous solution of tetrapropylammonium hydroxide (TPAOH) was used to further improve the diffusion property. Compared with the parent TS-1, the secondary pore volume was all increased. The developed hierarchical Ti-rich TS-1 zeolites were also assessed in hydroxylation of phenol. It was confirmed that hierarchical Ti-rich titanium silicalite-1 zeolites can improve the catalytic activity in phenol conversion considerably.
Hierarchical ZSM-5 zeolites of controlled porous structure were realized by the cooperative direction of organosilanes and tetrapropylammonium hydroxide.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.